InoCure delivers next generation 3D cell culture scaffolds for more reliable results of cell culture. We are improving efficacy of early drug screening and minimizing use of animals in toxicological studies. InoCure operates in mixed B2B and B2B2B business models targeting on every laboratory using cells in their pipeline.
cells, drugtech, 3d
💡 You’re a corporate or investor and looking for startups that are innovating in the same market as InoCure? We’re happy to assist you with our Startup Sourcing service.